Literature DB >> 11122459

Xenogeneic islet re-transplantation in mice triggers an accelerated, species-specific rejection.

F Triponez1, J Oberholzer, P Morel, C Toso, D Yu, N Cretin, L Buhler, P Majno, G Mentha, J Lou.   

Abstract

Xenogeneic islets could provide an unlimited source of tissue for the treatment of diabetes, and could in theory be transplanted repeatedly in a recipient. However, little is known on the consequences of islet re-transplantation in a recipient who has rejected a first graft. In this study, we investigated the functional consequence of xeno islet re-transplantation in mice sensitized with islets from different species. Sprague-Dawley (SD)-rat islets transplanted in sensitized C57/Bl6 mice that rejected either SD- or Lewis-rat islets underwent accelerated rejection. However, accelerated rejection was not found in mice sensitized with pig or human islets, suggesting that accelerated rejection was species specific. Immunohistochemistry showed increased binding of antibodies and accelerated leucocyte infiltration on re-grafted islets in sensitized mice. In situ apoptosis detection indicated that islet cell apoptosis was correlated with the time of leucocyte infiltration, but not with the time of antibody binding. In vitro experiments with cultured islet cells showed that although antibody binding was increased after incubation with sensitized mouse serum, islet cell cytotoxicity was not increased, suggesting that humoral immunity did not play a direct role in islet destruction. These results indicate that there is a cell-mediated, species-specific accelerated rejection after re-transplantation of xenogeneic islets.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122459      PMCID: PMC2327100          DOI: 10.1046/j.1365-2567.2000.00130.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Human NK cell and ADCC reactivity against xenogeneic porcine target cells including fetal porcine islet cells.

Authors:  M Kumagai-Braesch; M Satake; Y Qian; J Holgersson; E Möller
Journal:  Xenotransplantation       Date:  1998-05       Impact factor: 3.907

2.  Effect of GK1.5 monoclonal antibody dosage on survival of pig proislet xenografts in CD4+ T cell-depleted mice.

Authors:  C J Simeonovic; R Ceredig; J D Wilson
Journal:  Transplantation       Date:  1990-05       Impact factor: 4.939

3.  Intact pancreatic islet function despite humoral xenorecognition in the pig-to-monkey combination.

Authors:  V Mirenda; B Le Mauff; F Boeffard; A Cassard; N Jugeau; J P Soulillou; I Anegon
Journal:  Transplantation       Date:  1998-12-15       Impact factor: 4.939

4.  Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts.

Authors:  R G Gill; A S Rosenberg; K J Lafferty; A Singer
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

5.  Role of CD4+ T-lymphocytes in rejection by mice of fetal pig proislet xenografts.

Authors:  J D Wilson; C J Simeonovic; J H Ting; R Ceredig
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

6.  Automated method for isolation of human pancreatic islets.

Authors:  C Ricordi; P E Lacy; E H Finke; B J Olack; D W Scharp
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

7.  Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model.

Authors:  J Oberholzer; D Yu; F Triponez; N Cretin; E Andereggen; G Mentha; D White; L Buehler; P Morel; J Lou
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

8.  Cross-species reactivity of a panel of antibodies with monkey and porcine tissue.

Authors:  A S Carter; L Cerundolo; D D Koo; N A Rust; P J Morris; S V Fuggle
Journal:  Xenotransplantation       Date:  1999-05       Impact factor: 3.907

Review 9.  Clinical islet transplantation: a review.

Authors:  J Oberholzer; F Triponez; J Lou; P Morel
Journal:  Ann N Y Acad Sci       Date:  1999-06-18       Impact factor: 5.691

10.  Resistance of established porcine islet xenografts to humoral rejection by hyperimmune sera.

Authors:  W A Gourlay; J J O'Neil; W W Hancock; A P Monaco; T Maki
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

View more
  5 in total

1.  Intracerebral xenotransplantation of semipermeable membrane- encapsuled pancreatic islets.

Authors:  Zhao-Liang Xin; Song-Lin Ge; Xiao-Kang Wu; Yan-Jie Jia; Han-Tao Hu
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

2.  An immunosufficient murine model for the study of human islets.

Authors:  Gaoping Zhao; Daniel J Moore; James I Kim; Kang Mi Lee; Matthew O'Connor; Maozhu Yang; Andrew F Marshall; Ji Lei; Christian Schuetz; James F Markmann; Shaoping Deng
Journal:  Xenotransplantation       Date:  2014-07-09       Impact factor: 3.907

3.  Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model.

Authors:  Ping Wang; Christian Schuetz; Alana Ross; Guangping Dai; James F Markmann; Anna Moore
Journal:  Radiology       Date:  2012-12-21       Impact factor: 11.105

Review 4.  Multifunctional Islet Transplantation Hydrogel Encapsulating A20 High-Expressing Islets.

Authors:  Xue Bai; Qilin Pei; Chunyi Pu; Yi Chen; Sirong He; Bin Wang
Journal:  Drug Des Devel Ther       Date:  2020-09-29       Impact factor: 4.162

5.  A theranostic small interfering RNA nanoprobe protects pancreatic islet grafts from adoptively transferred immune rejection.

Authors:  Ping Wang; Mehmet V Yigit; Chongzhao Ran; Alana Ross; Lingling Wei; Guangping Dai; Zdravka Medarova; Anna Moore
Journal:  Diabetes       Date:  2012-08-24       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.